Literature DB >> 19192639

Ameloblastic carcinoma of the maxillary sinus.

Francesca Angiero1, Roberto Borloni, Maurizia Macchi, Michele Stefani.   

Abstract

Ameloblastic carcinoma is a very rare malignant odontogenic neoplasm of the mandible and maxilla, accounting for some 66 reported cases. The case of a 68-year-old man who presented a fistula with orosinus communication of 14-year duration that, after anti-aggregant therapy, began bleeding is reported. The initial microscopic evaluation of the biopsy and radiographic findings were consistent with benign peripheral ameloblastoma without cellular atypia and extensive fields of acantomatous pattern, but immunohistochemical investigation found strong positivity for Bcl-2, cytokeratins CAM 5 and 6, and for Ki-67/MIB-1, changing our diagnosis. The treatment consisted of left maxillary resection followed by reconstruction. Cellular features of malignancy in the surgical specimen confirmed the diagnosis of ameloblastic carcinoma. This case of an aggressive ameloblastic carcinoma of the maxillary gingiva that presented with an unusual histological pattern illustrates that these tumors can create a diagnostic challenge that may require extensive surgical sampling and/or removal to establish the diagnosis. Immunohistochemically analyzed expression of bcl-2 protein, cytokeratins CAM 5 and 6, and Ki-67/MIB-1 antigen serve to characterize the cyto-differentiation and cellular activity of ameloblastic carcinoma.

Entities:  

Mesh:

Year:  2008        PMID: 19192639

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Nucleolar organizing regions and alpha-smooth muscle actin expression in a case of ameloblastic carcinoma.

Authors:  Kavitha P Kamath; M Vidya; Nandaprasad Shetty; Bhavana V Karkera; Hemanth Jogi
Journal:  Head Neck Pathol       Date:  2010-03-24

2.  Ameloblastic carcinoma: A clinicopathologic dilemma - Report of two cases with total review of literature from 1984 to 2012.

Authors:  Indu Bhusan Kar; R V Subramanyam; Niranjan Mishra; Akhilesh Kumar Singh
Journal:  Ann Maxillofac Surg       Date:  2014-01

3.  Prominent response with helical tomotherapy in recurrent ameloblastic carcinoma of maxillary sinus: a case report.

Authors:  Timur Koca; Hamit Başaran; Deniz Arslan; Duygu Sezen; Zümrüt Arda Cerkeşli; Ozlem Kılınç; Sibel Karaca; Cumhur Ibrahim Başsorgun; Hilmi Onder Okay; Münir Demirci
Journal:  Radiat Oncol       Date:  2014-07-15       Impact factor: 3.481

4.  Primary ameloblastic carcinoma of the maxilla: A case report and literature review.

Authors:  Narikazu Uzawa; Miho Suzuki; Chika Miura; Nobuyoshi Tomomatsu; Toshiyuki Izumo; Kiyoshi Harada
Journal:  Oncol Lett       Date:  2014-10-31       Impact factor: 2.967

Review 5.  Ameloblastic carcinoma of the mandible: Report of a case and review.

Authors:  Shreenivas Kallianpur; Sanjay Jadwani; Biswajit Misra; U S Sudheendra
Journal:  J Oral Maxillofac Pathol       Date:  2014-09

6.  Ameloblastic carcinoma of the maxilla: a report of two cases and a review of the literature.

Authors:  Benjamin Fomete; Ezekiel Taiwo Adebayo; Godwin Iko Ayuba; Uche Albert Okeke
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2016-02-15

7.  Ameloblastic carcinoma of the maxilla: A case report and an updated review of the literature.

Authors:  Alessandro Moro; Enrico Foresta; Giulio Gasparini; Sandro Pelo; Mario Forcione; Enrico Giuseppe Cristallini; Marco Toraldo; Cardarelli Lorenzo; Marco Falchi; Gianmarco Saponaro
Journal:  Oncol Lett       Date:  2016-10-17       Impact factor: 2.967

8.  Ameloblastic carcinoma: An analysis of 12 cases with a review of the literature.

Authors:  Jia Li; Hongming DU; Peng Li; Jingkui Zhang; Weidong Tian; Wei Tang
Journal:  Oncol Lett       Date:  2014-06-05       Impact factor: 2.967

9.  A Rare Presentation of Ameloblastic Carcinoma of the Sinus Cavity and Skull Base.

Authors:  Kelly Landeen; William C Spanos; Steven Powell
Journal:  Cureus       Date:  2019-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.